Vitamin K: A potential Liver Cancer treatment way

Sofia Dahlberg; Ulf Schött

doi:10.17352/ahr.000017

Vitamin K: A potential Liver Cancer treatment way

Forskningsoutput: Tidskriftsbidrag › Översiktsartikel › Peer review

Sammanfattning

A review on different vitamin K1-3 effects on hepatocellular cancer and their tumour cell biology mechanism indicate possible synergistic treatment strategies. Monitoring of dysfunctional carboxylation of the vitamin K dependent coagulation factor II, with the commercial ELISA test PIVKA-II has been used as a hepatocellular cancer marker. Its relevance is also reviewed. Currently the PIVKA-II test has been withdrawn due to marketing reasons by Stago

Originalspråk	engelska
Sidor (från-till)	049-052
Tidskrift	Archives of Hepatitis Research
Volym	3
Nummer	2
DOI	https://doi.org/10.17352/ahr.000017
Status	Published - 2017

Ämnesklassifikation (UKÄ)

Cancer och onkologi

Tillgång till dokument

10.17352/ahr.000017

https://www.peertechz.com/articles/vitamin-k-a-potential-liver-cancer-treatment-way.pdf

Citera det här

@article{4e92a724a8dd4983be191f63564e9d14,

title = "Vitamin K: A potential Liver Cancer treatment way",

abstract = "A review on different vitamin K1-3 effects on hepatocellular cancer and their tumour cell biology mechanism indicate possible synergistic treatment strategies. Monitoring of dysfunctional carboxylation of the vitamin K dependent coagulation factor II, with the commercial ELISA test PIVKA-II has been used as a hepatocellular cancer marker. Its relevance is also reviewed. Currently the PIVKA-II test has been withdrawn due to marketing reasons by Stago",

author = "Sofia Dahlberg and Ulf Sch{\"o}tt",

year = "2017",

doi = "10.17352/ahr.000017",

language = "English",

volume = "3",

pages = "049--052",

journal = "Archives of Hepatitis Research",

issn = "2641-2977",

publisher = "Peertechz",

number = "2",

}

TY - JOUR

T1 - Vitamin K: A potential Liver Cancer treatment way

AU - Dahlberg, Sofia

AU - Schött, Ulf

PY - 2017

Y1 - 2017

N2 - A review on different vitamin K1-3 effects on hepatocellular cancer and their tumour cell biology mechanism indicate possible synergistic treatment strategies. Monitoring of dysfunctional carboxylation of the vitamin K dependent coagulation factor II, with the commercial ELISA test PIVKA-II has been used as a hepatocellular cancer marker. Its relevance is also reviewed. Currently the PIVKA-II test has been withdrawn due to marketing reasons by Stago

AB - A review on different vitamin K1-3 effects on hepatocellular cancer and their tumour cell biology mechanism indicate possible synergistic treatment strategies. Monitoring of dysfunctional carboxylation of the vitamin K dependent coagulation factor II, with the commercial ELISA test PIVKA-II has been used as a hepatocellular cancer marker. Its relevance is also reviewed. Currently the PIVKA-II test has been withdrawn due to marketing reasons by Stago

U2 - 10.17352/ahr.000017

DO - 10.17352/ahr.000017

M3 - Review article

VL - 3

SP - 49

EP - 52

JO - Archives of Hepatitis Research

JF - Archives of Hepatitis Research

SN - 2641-2977

IS - 2

ER -

Vitamin K: A potential Liver Cancer treatment way

Sammanfattning

Ämnesklassifikation (UKÄ)

Tillgång till dokument

Fingeravtryck

Citera det här